Author Archives: Jason Kitchell
SPECT scans identify high-risk heart failure patients
Japanese investigators at Osaka University analyzed data from heart failure patients who underwent iodine-123 metaiodobenzylguanidine (I-123 MIBG) SPECT scans. They found patients with higher levels of blood-flow defects on SPECT scans were significantly more at risk of dying from cardiac events than those with low levels. SPECT scans identify high-risk heart failure patients https://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&ItemID=133789
SPECT can predict how long patients with epilepsy will live free of seizures after brain surgery.
German researchers recently published a study in the Journal of Nuclear Medicine, demonstrating that SPECT imaging prior to temporal lobe epilepsy surgery to remove seizure causing area can predict whether the patient will be free of seizures post-surgery. SPECT predicts outcomes in brain surgery for epilepsy (auntminnie.com)
Domestic Production Of Mo-99 Gets A Big Boost from the NNSA
The National Nuclear Security Agency, a semiautonomous department of the DOE announced it is awarding North Star Medical Technologies with $37 million in cost-shared funding under two-cooperative agreements. This funding will allow North Star to finish the first phase of its $80 million facility in Beloit, Wis., and expand production at its research reactor in Missouri. The NNSA also provided cost-shared funding to SHINE Medical Technologies, of Janesville, Wis.; Niowave, of Lansing, Mich.; and Northwest Medical Isotopes, based in Corvallis, Ore. All four of these companies are pursuing the production of Mo-99 using a different non-HEU technology. Link:
Are commercial payors denying your SPECT/CT claims? Maybe this will help.
If commercial payors are denying your SPECT/CT reimbursement claims the SNMMI has a medical necessity letter you can personalize to assist with informing the payor about the significant changes in the codes since 2020. Link: SNMMI offers letter to contest SPECT/CT denials (auntminnie.com)
Shine Medical Technologies continues its expansion of Mo-99 production
Shine Medical Technologies announced recently, its plans to build a M0-99 production facility in the EU. The company said the site chosen is in Veendam in the Netherlands. Mo-99 production is expected to commence in early 2023. Link: Shine selects Netherlands site for new facility (auntminnieeurope.com)
Experimental Machine Learning (AI) technique improves SPECT images
Researchers presented findings recently in the June issue of the International Journal of Cognitive Computing in Engineering, suggesting certain machine learning algorithms combining several SPECT images can produce sharper scans. The technique is called “image fusion”, and the researchers suggest these enhanced SPECT scans may improve clinical diagnosis. Link: ‘Image fusion’ significantly enhances scan quality and may improve clinical diagnoses (healthimaging.com)
As the Pandemic Wanes, SNMMI Provides New Guidance for the Reintroduction of V/Q Scans
As we see the vaccination of the public expand, it may be time to reintroduce nuclear medicine SPECT ventilation scanning for those suspected of possible lung embolism. “The group [SNMMI] said its new guidance was based on the availability of three vaccines for the SARS-CoV-2 virus, as well as safety measures that have been adopted for performing V/Q scans.” SNMMI promises to continue to review and update the guidance as conditions demand. SNMMI issues new guidelines on V/Q scans (auntminnie.com)
If Administration Doesn’t Understand the Benefits of Nuclear Medicine, This Seminar May Be Just What the Doctor Ordered
All too often we see nuclear medicine departments in need of capital to improve their operations. Unfortunately, the benefits of Nuclear Medicine aren’t always self-evident to administration. And, frequently Nuclear Medicine practitioners struggle to make the case. Either situation is not good for patient care. A seminar, offered SNMMI Outreach may assist you as you learn proven techniques to demonstrate the clinical and financial benefit Nuclear Medicine brings to the health care facility. Display event – Getting Your Foot in Your Administrator’s Door (snmmi.org)
North Star expands Production of non-uranium based Mo-99 for Tc-99m generators.
North Star Medical Radioisotopes announced an expansion of its collaboration with Ion Beam Applications (IBA) to increase the availability of non-uranium-based Mo-99. In this expanded partnership, IBA will supply up to 8-of its electron beam accelerators to North Star expanding the use of North Star’s technology here and outside of the United States. As demand for nuclear medicine procedures continue to expand globally, the need for increased Tc-99m generator production capacity is critical for serving the expansion of nuclear medicine around the world. Link: NorthStar teaming up with cancer therapy leader to bolster global radioisotope supply (healthimaging.com)
New SPECT Technique Proven to Distinguish Dementia with Lewy Bodies from Alzheimer’s Disease
Lisbon researchers acquired imaging data from patients from 1996-1999 and followed them until their deaths. Utilizing (I-123) FP-CIT SPECT imaging they demonstrated an ability to differentiate dementia from Lewy bodies from Alzheimer’s. These results were confirmed upon autopsy. The authors said for the first time they were able to demonstrate that this compound not only separated dementia from Alzheimer’s but from Parkinson’s too. Read more.